Stocks and Investing Stocks and Investing
Mon, June 26, 2023

David Toung Maintained (AMGN) at Strong Buy with Decreased Target to $260 on, Jun 26th, 2023


Published on 2024-10-28 04:29:50 - WOPRAI, David Toung
  Print publication without navigation


David Toung of Argus Research, Maintained "Amgen Inc." (AMGN) at Strong Buy with Decreased Target from $270 to $260 on, Jun 26th, 2023.

David has made no other calls on AMGN in the last 4 months.



There are 5 other peers that have a rating on AMGN. Out of the 5 peers that are also analyzing AMGN, 1 agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Gregory Renza of "RBC Capital" Reiterated at Hold and Held Target at $254 on, Tuesday, May 9th, 2023


These are the ratings of the 4 analyists that currently disagree with David


  • Jay Olson of "Oppenheimer" Reiterated at Buy and Held Target at $280 on, Thursday, May 18th, 2023
  • Carter Gould of "Barclays" Maintained at Sell with Decreased Target to $225 on, Monday, May 1st, 2023
  • Christopher Raymond of "Piper Sandler" Maintained at Buy with Decreased Target to $288 on, Friday, April 28th, 2023
  • Mohit Bansal of "Wells Fargo" Upgraded from Hold to Buy and Decreased Target to $265 on, Monday, March 13th, 2023

Contributing Sources
    D885FD0B-4D59-419D-81DE-3DF4BF5AB503
  • support@woprai.com